Objective: To investigate the immunopathological significance of CD40=CD40 ligand system for B cell hyperactivation in SLE patients, the expression and the function of CD40 on B cells were compared with those of normal controls.
Methods: Expression of CD40 was evaluated by flow cytometry. DNA synthesis of B cells were measured by 3H–TdR incorporation. Antibody production was assessed by ELISA.
Results: There was no significant difference between SLE and normal controls in CD40 expression on peripheral blood B cells. Recombinant CD40 ligand-leucine zipper fusion protein (CD40L-LZ) 3significantly enhanced 3H ÿ TdR incorporation by both SLE and normal B cells–P < 0:01ƒ. H ÿ TdR incorporation of SLE B cells without stimuli (P < 0:001) and with CD40L-LZ stimulation (p < 0:05) were significantly lower in SLE patients compared with normal controls. Active SLE B cells spontaneously produced significantly larger amounts of total IgG than normal B cells (P < 0:05). CD40L-LZ significantly increased the production of total IgG by SLE B cells (P < 0:05), but not by normal B cells. Active SLE B cells spontaneously produced IgG anti-dsDNA and IgG anti-ssDNA antibodies. CD40L-LZ significantly increased the production of these autoantibodies by SLE B cells (P < 0:05). B cells from normal controls do not produce these autoantibodies spontaneously nor in response to CD40L-LZ.
Conclusion: These findings indicate that signalling via CD40 plays an important role in B cell proliferation and autoantibody production in human SLE.
Burlingame R , Boey M , Starkebaum G et al. The central role of chromatin in autoimmune responses to histones and DNA in SLE . J Clin Invest1994; 94: 184–192 .
2.
Radic M , Weigert M . Genetic and structural evidence for antigen selecton of anti-DNA antibodies . Annu Rev Immunol1994; 12: 487–520 .
3.
Pharm B et al.. T lymphocyte activation in systemic lupus erythematosus analyzed by proliferative response to nucleoplasmic proteins on nitrocellulose immunoblots . Clin Exp Immunol1989; 77: 168–174 .
4.
Crow M et al.. Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus . J Clin Invest1994; 94: 345–352 .
5.
Suenaga R , Abdou N . Cationic and high affinity serum IgG anti-dsDNA antibodies in active lupus nephritis . Clin Exp Immunol1993; 94: 418–422 .
6.
Gavalchin J , Datta S . The NZBSWR model of lupus nephritis II. Autoantibodies deposted in renal lesions show a restricted idiotypic diversity . J Immunol1987; 138: 138–148 .
7.
Do Valerio R , Bernstein K , Varghese E , Lefkowith J . Murine lupus glomerulotropic monoclonal antibodies exhibit differing specificities but bind via a common mechanism . J Immunol1995; 155: 2258–2268 .
8.
Hara M et al.. Differential abnormalilty in cell-cycle stage of peripheral B cells from patients with systemic lupus erythematosus . Rheumatol Int1987; 7: 83–87 .
9.
Kitani et al. Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with SLE . Clin exp Immunol1989; 77: 31–36 .
10.
Kitani A et al. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression . Clin exp Immunol1992; 88: 75–83 .
11.
Clark L , Foy T , Noelle R . CD40 and its ligand . Adv Immunol1996; 63: 43–78 .
12.
Roy M et al. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells . J Immunol1993; 151: 2497–2510 .
13.
Valle A et al. Activation of human B lymphocytes through CD40 and interleukin 4 . Eur J Immunol1989; 19: 1463–1467 .
14.
Saeland S , Duvert V , Moreau I , Banchereau J . Human B cell precursors proliferate and express CD23 after CD40 ligation . J Exp Med1993; 178: 113–120 .
15.
Klaus S , Berberich I , Shu G et al. CD40 and its ligand in the regulation of humoral immunity . Semin Immunol1994; 6: 279–286 .
16.
Barrett T , Shu G , Clark E . CD40 signalling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells . J Immunol1991; 146: 1722–1729 .
17.
Ranheim E , Kipps T . Activated T cells induce expression of B7=BB-1 on normal or leukemic B cells through a CD40-dependent signal . J Exp Med1993; 177: 925–935 .
18.
Ranheim E , Kipps T . Tumor necrosis factor-a facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L . Cell Immunol1995; 161: 226–235 .
19.
Roy M et al. Studies on the interdependence of gp39 and B7 expression and function during antigen specific immune responses . Eur J Immuno1994; 25: 596–603 .
20.
Allen R et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome . Science1993; 259: 990–993 .
21.
Aruffo A et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome . Cell1993; 72: 291–300 .
22.
Fuleihan R et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM . Proc Natl Acad Sci USA1993; 90: 2170–2173 .
23.
Ramesh N et al. Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1) . Int Immunol1993; 5: 769–773 .
24.
DiSanto J et al. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM . Nature1993; 361: 541–543 .
25.
Conley M et al. Hyper IgM syndrome associated with defective CD40-mediated B cell activation . J Clin Invest1994; 4: 1404–1409 .
26.
Tan E et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum1982; 25: 1271–1277 .
27.
Bombardier C et al. Derivation of the SLEDAI. A disease activity index for lupus patients . Arthritis Rheum1992; 35: 630–640 .
28.
Fanslow W et al. Structural characteristics of CD40 ligand that determine biological function . Semin Immunol1994; 6: 267–278 .
29.
Emlen W , Niebur J , Kadera R . Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus . J Immunol1994; 152: 3685–3692 .
30.
Tsubata T , Wu J , Honjo T . B cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40 . Nature1993; 364: 645–648 .
31.
Holder MJ et al. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction . Eur J Immunol1993; 23: 2368–2371 .
32.
Armitage R , Macduff B , Spriggs M et al. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines . J Immunol1993; 150: 3671–3680 .
33.
Cocks B et al. IL-13 induces proliferation and differentiation of human B cells activated by CD40 ligand . Int Immunol1993; 5: 657–663 .
34.
Rousset F et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes . Proc Natl Acad Sci1992; 89: 1890–1893 .
35.
Kuhne M et al. Assembly and regulation of the CD40 receptor complex in human B cells . J Exp Med1997; 186: 337–342 .
36.
Llorente L et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus . Eur Cytokine Netw1993; 4(6): 421–427 .
37.
Tanaka Y . Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus . J Immunol1988; 141(9): 3043–3049 .
38.
Tsokos G . Lymphocutes, cytokines, inflammation, and immune trafficking . Curr Opin Rheumatol1996; 8(5): 395–402 .
39.
Ma J et al. Autoimmune lpr/lpr mice deficient in CD40 ligand . J Immunol1996; 157: 417–426 .
40.
Peng S et al. T cell regulation and CD40 ligand dependence in murine systemic autoimmunity . J Immunol1997; 158: 2464–2470 .
41.
Early G , Zhao W , Burns C . Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand BlackNew Zealand White Mice . J Immunol1996; 157: 3159–3164 .
42.
Mohan C , Shi Y , Laman J et al. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis . J Immunol1995; 154: 1470–1480 .
43.
Desai-Mehta A , Lu L , Ramsey-Goldman R et al. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production . J Clin Invest1996; 97(9): 2063–2073 .
44.
Koshy M , Berger D , Crow M . Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes . J Clin Invest1996; 98(3): 826–837 .
